Publication: Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies
dc.contributor.author | Tokalı F. S. | |
dc.contributor.author | Şenol H. | |
dc.contributor.author | Yetke H. İ. | |
dc.contributor.author | Hacıosmanoğlu E. | |
dc.contributor.institutionauthor | ŞENOL, HALIL | |
dc.contributor.institutionauthor | YETKE, HANDE İPEK | |
dc.contributor.institutionauthor | HACIOSMANOĞLU, EBRU | |
dc.date.accessioned | 2023-10-05T21:50:20Z | |
dc.date.available | 2023-10-05T21:50:20Z | |
dc.date.issued | 2023-09-01 | |
dc.identifier.citation | Tokalı F. S., Şenol H., Yetke H. İ., Hacıosmanoğlu E., "Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies", ARCHIV DER PHARMAZIE, ss.1-16, 2023 | |
dc.identifier.doi | 10.1002/ardp.202300423 | |
dc.identifier.endpage | 16 | |
dc.identifier.issn | 0365-6233 | |
dc.identifier.startpage | 1 | |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/10.1002/ardp.202300423 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12645/38570 | |
dc.relation.ispartof | ARCHIV DER PHARMAZIE | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Eczacılık | |
dc.subject | Meslek Bilimleri | |
dc.subject | Farmasötik Kimya | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Pharmacology and Therapeutics | |
dc.subject | Professional Sciences | |
dc.subject | Pharmaceutical Chemistry | |
dc.subject | Health Sciences | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Clinical Medicine (MED) | |
dc.subject | Life Sciences (LIFE) | |
dc.subject | PHARMACOLOGY & TOXICOLOGY | |
dc.subject | PHARMACOLOGY & PHARMACY | |
dc.subject | Farmakoloji | |
dc.subject | Farmakoloji, Toksikoloji ve Eczacılık (çeşitli) | |
dc.subject | Genel Farmakoloji, Toksikoloji ve Eczacılık | |
dc.subject | Farmakoloji (tıbbi) | |
dc.subject | İlaç Rehberleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Pharmacy | |
dc.subject | Pharmacology | |
dc.subject | Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | |
dc.subject | General Pharmacology, Toxicology and Pharmaceutics | |
dc.subject | Pharmacology (medical) | |
dc.subject | Drug Guides | |
dc.subject | Life Sciences | |
dc.title | Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies | |
dc.type | Article | |
dspace.entity.type | Publication | |
local.avesis.id | 0bb547a7-089a-45ee-817c-aa94b9c25d99 | |
relation.isAuthorOfPublication | 1c5c41d3-57c1-4cd3-b92a-b67095184ea9 | |
relation.isAuthorOfPublication | 657b5cac-96e2-402a-bc8b-3def08da1caf | |
relation.isAuthorOfPublication | fffb1a2f-62c4-40ee-8fc4-f0f3e62523b9 | |
relation.isAuthorOfPublication.latestForDiscovery | 1c5c41d3-57c1-4cd3-b92a-b67095184ea9 |